Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown Origin
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Dermatology"
DOI: 10.1001/jamadermatol.2024.1464
Abstract: Key Points Question What is the efficacy and safety of 200-mg oral abrocitinib administered once daily in adults with moderate to severe prurigo nodularis (PN) or chronic pruritus of unknown origin (CPUO)? Findings In this… read more here.
Keywords: chronic pruritus; prurigo nodularis; pruritus unknown; pruritus ... See more keywords
Plasma metabolomic profiling reveals a novel circulating biomarker signature in chronic pruritus of unknown origin
Sign Up to like & getrecommendations! Published in 2024 at "Scientific Reports"
DOI: 10.1038/s41598-024-67170-y
Abstract: Chronic pruritus of unknown origin (CPUO) is characterized by chronic itch for 6 weeks or greater without an identifiable primary cause. Studies are needed to investigate circulating blood biomarkers to elucidate disease pathogenesis. The objective… read more here.
Keywords: chronic pruritus; unknown origin; pruritus unknown; cpuo patients ... See more keywords